Trend
DailyUptrend (confirmed)
4 hourLeaning Bullish
1 hourStrong Bullish
15 minStrong Bullish
5 minSymmetric Triangle
Daily trend turns down below $0.90
Key levels
Resistance$1.36
Resistance$1.28
Support$1.21
Support$1.07
Latest news & SEC filings
EarningsDefinitive Healthcare Posts Q3 2026 Results
EarningsDefinitive Healthcare posts quarterly profit of $0.06 per share, topping $0.04 forecast
NewsDefinitive Healthcare names executives to support AI-powered initiatives
All DH news →Definitive Healthcare provides healthcare data and analytics through a subscription-based SaaS platform. Its products cover healthcare providers, claims, and consumer data, serving life sciences companies, healthcare providers, and diversified organizations such as IT firms and financial institutions. The company operates primarily in the United States.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Technology
SEPT Low Target
$0.70
SEPT Mid Target
$1.00
SEPT High Target
$1.50
Analyst Consensus
$1.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DH.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$2.09
31
Moat Score
NONE
5/9
Piotroski Score
-1.8
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Krantz Jason Ronald | director 10% owner | Sale | 12,166 | $14K | Nov 1, 2026 |
| Heller Casey | officer | Sale | 1,881 | $2K | Nov 1, 2026 |
| Ritchey Clay Brian | director officer | Buy | 2,626,263 | - | Oct 23, 2026 |
| Heller Casey | officer | Sale | 12,542 | $12K | Oct 1, 2026 |
| Paris Jonathan | officer | Sale | 7,729 | $7K | Oct 1, 2026 |
| Stephenson Scott G | director | Buy | 189,190 | - | Jun 4, 2026 |
| Winters Kathleen A | director | Buy | 189,190 | - | Jun 4, 2026 |
| Chilukuri Sastry | director | Buy | 189,190 | - | Jun 4, 2026 |
| Hamood Samuel A | director | Buy | 189,190 | - | Jun 4, 2026 |
| Heller Casey | officer | Sale | 164,377 | $163K | Jun 1, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
-4.2%
3yr Revenue CAGR
2.8%
EPS Growth YoY
63.28%
FCF Growth YoY
-19.2%
Revenue Trend
SLOWING
SEPT Investing tracks real-time dark pool institutional trades for DH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:53:28 | $1.28 | 1,000 | $$1K | SELL |
| 20:40:27 | $1.28 | 2,000 | $$3K | SELL |
| 20:40:18 | $1.28 | 4,000 | $$5K | SELL |
| 20:37:29 | $1.29 | 4,906 | $$6K | BUY |
| 20:23:11 | $1.28 | 3,000 | $$4K | SELL |
5 dark pool trades shown · $$19K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Definitive Healthcare Corp. (DH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Definitive Healthcare Corp. (DH) is at $1.25, down 2.34% (-$0.03) at the Nov 12, 2026 close.
Latest DH news — Nov 6, 2026: Definitive Healthcare Posts Q3 2026 Results · Nov 5, 2026: Definitive Healthcare posts quarterly profit of $0.06 per share, topping $0.04 forecast
The average analyst price target for DH is $1.00, ranging from $1 to $2, based on 3 analysts. Latest: Morgan Stanley maintains on Aug 11, 2026.
Analyst ratings for DH: 0 Buy, 2 Hold, 1 Sell — consensus Hold.
DH last reported on Aug 10, 2026: EPS $0.05 vs $0.04 expected — a beat of 17.1%.
Yes. DH's dividend yield is 1.03%.
Definitive Healthcare Corp. reported $152M of debt and $171M of cash (Jun 30, 2026).
Support: $1.21, $1.07, $1.00. Resistance: $1.28, $1.36, $1.50.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 6, 2026: Definitive Healthcare Posts Q3 2026 Results · Nov 5, 2026: Definitive Healthcare posts quarterly profit of $0.06 per share, topping $0.04 forecast · Nov 5, 2026: Definitive Healthcare names executives to support AI-powered initiatives